Full Press Release Details
BOTHELL, Wash.,April 30, 2025/PRNewswire/ --BioLife Solutions, Inc. (NASDAQ:BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the Company's first quarter 2025 financial results will be released after market close onThursday, May 8, 2025. The Company will host a conference call and live webcast at4:30pm ET(1:30pm PT) that day. Management will provide an overview of the Company's financial results and give a general business update.
To access the webcast, log onto the Investor Relations page of the BioLife Solutions website athttps://www.biolifesolutions.com/earnings.In addition, the conference call will be accessible by dialing toll-free 1-877-344-7529 or 1-412-317-0088 for international callers. A webcast replay will be available approximately two hours after the call and will be archived onhttps://investors.biolifesolutions.comfor 90 days.
About BioLife Solutions
BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visitwww.biolifesolutions.comor follow BioLife onLinkedInandX.
At the Company
Troy Wichterman
[email protected]
Investors
Alliance Advisors IR
Jody Cain
(310) 691-7100
[email protected]
SOURCE BioLife Solutions, Inc.
| Media & Investor Relations | ||
| At the CompanyTroy Wichterman | ||
| Chief Financial Officer | ||
| (425) 402-1400 | ||
| [email protected]InvestorsAlliance Advisors IRJody Cain(310) 691-7100[email protected] |